Expression of purification of recombinant human N-formyl-L-leucyl-L-phenylalanine (FMLP) receptor

Biochemical Pharmacology

Volumn 54, Issue 3, 1997, Pages 381-390

  Lala, Amitabha ^a   Sojar, Hakimuddin T ^a   De Nardin, Ernesto ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibody; FMLP; Neutrophil; Purification; Receptor; Recombinant

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; POLYCLONAL ANTIBODY; RECEPTOR PROTEIN; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GEL FILTRATION CHROMATOGRAPHY; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOBLOTTING; LIGAND BINDING; MOLECULAR WEIGHT; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION;

ANTIBODIES; BLOTTING, WESTERN; CELL LINE; CLONING, MOLECULAR; ESCHERICHIA COLI; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; NEUTROPHILS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 0030763381     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00191-3     Document Type: Article

References (42)

1. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairn R, Becker EL and Ward P, Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem 259: 5430-5439, 1984.
2. Showell HJ, Freer RJ, Zigmond SH, Schiffmann E, Aswanikumar E, Corcoran BA and Becker E, The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J Exp Med 141: 1154-1169, 1976.
3. Aswanikumar S, Corcoran BA, Schiffman E, Day AR, Freer RJ, Showell HJ, Becker EL and Pert CB, Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun 74: 810-817, 1977.
4. 125I-chemotactic peptide by human neutrophils. J Biol Chem 254: 10700-10706, 1979.
5. Williams LT, Snyderman R, Pike MC and Lefkowitz RJ, Specific receptor site for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 74: 1204-1208, 1977.
6. Koo C, Lefkowitz RJ and Snydermann R, Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor of human polymorphonuclear leukocytes. J Clin Invest 72: 748-753, 1983.
7. Niedel J, Davis J and Cuatrecasas P, Covalent affinity labeling of the formyl peptide chemotactic receptor. J Biol Chem 255: 7063-7066, 1980.
8. De Nardin E, Radel SJ and Genco RJ, Isolation and partial characterization of the formyl peptide receptor components on human neutrophils. Biochem Biophys Res Commun 174: 84-89, 1991.
9. Malech HL, Gardner JP, Heiman DF and Rosenzweig SA, Asparagine-linked oligosaccharides on formyl peptide chemotactic receptors of human phagocytic cells. J Biol Chem 260: 2509-2514, 1985.
10. Boulay F, Tardif M, Brouchon L and Vignais P, Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun 168: 1103-1109, 1990.
11. Boulay F, Tardif M, Brouchon L and Vignais P, The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29: 11123-11133, 1990.
12. Radel SJ, Genco RJ and De Nardin E, Localization of ligand-binding regions of human formyl peptide receptor. Biochem Int 25: 745-753, 1991.
13. Radel SJ, Genco RJ and De Nardin E, Structural and functional characterization of the human formyl peptide receptor ligand-binding region. Infect Immunol 62: 1726-1732, 1994.
14. Lala A, Sharma A, Sojar HT, Radel SJ, Genco RJ and DeNardin E, Recombinant expression and partial characterization of the human formyl peptide receptor. Biochim Biophys Acta 1178: 302-306, 1993.
15. Perez HD, Holmes R, Vilander LR, Adams RR, Manzana W, Jolley D and Andrew WH, Formyl peptide receptor chimeras define domains involved in ligand binding. J Biol Chem 268: 2292-2295, 1993.
16. Prossnitz ER, Schreiber RE, Bokoch GM and Ye RD, Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate. J Biol Chem 270: 10686-10694, 1995.
17. Prossnitz ER, Quehenberger O, Cochrane CG and Ye RD, The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling. Biochem J 294: 581-587, 1993.
18. Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG and Bokoch GM, Domains of human neutrophil N-formyl peptide receptor involved in G-protein coupling. J Biol Chem 269: 326-331, 1994.
19. Hoyle PC and Freer RJ, Isolation and reconstitution of the N-formylpeptide receptor from HL-60 derived neutrophils. FEBS Lett 167: 277-280, 1984.
20. Goetzl EJ, Foster DW and Goldman DW, Isolation and partial characterization of membrane protein constituents of human neutrophil receptors for chemotactic formylmethionyl peptides. Biochemistry 20: 5717-5722, 1981.
21. i proteins in the Sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor. J Biol Chem 267: 19757-19760, 1992.
22. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1989.
23. 2-adrenergic receptor: Purification and characterization. Biochemistry 23: 4510-4518, 1984.
24. Harlow E and Lane D, Antibodies: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988.
25. De Nardin E, De Luca C, Levine MJ and Genco RJ, Antibodies directed to the chemotactic factor receptor detect differences between chemotactically normal and defective neutrophils from LJP patients. J Periodontol 61: 609-617, 1990.
26. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
27. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
28. Dickinson DP, Kubiniec MK, Yoshimura F and Genco RJ, Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis. J Bacteriol 170: 1658-1665, 1988.
29. Heiman DF, Gardner JP, Apfeldorf WJ and Malech HL, Effects of tunicamycin on the expression and function of formyl peptide chemotactic receptors of differentiated HL-60 cells. J Immunol 136: 4623-4630, 1986.
30. 2+ dependent ATPase in human granulocytes. Biochim Biophys Acta 719: 556-568, 1982.
31. Studier FW, Rosenberg AH, Dunn JJ and Dubendorff JW, Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185: 60-89, 1990.
32. Tabor S and Richardson CC, DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc Natl Acad Sci USA 84: 4767-4771, 1987.
33. 3 receptors provides new insights into their maturation and structure. J Biol Chem 270: 6056-6061, 1995.
34. Peterson GL, Toumadje A, Johnson WC Jr and Schimerlik MI, Purification of recombinant porcine m2 muscarinic acetylcholine receptor from Chinese hamster ovary cells. Circular dichroism spectra and ligand binding properties. J Biol Chem 270: 17808-17814, 1995.
35. Lane MD, Slieker LJ, Olson TS and Martensen TM, Post-translational acquisition of ligand binding and tyrosine kinase domain function by the epidermal growth factor and insulin. J Recept Res 7: 321-354, 1987.
36. Stryer L, Biochemistry, 3rd Ed. W. H. Freeman, New York, 1988.
37. Michel H, Crystallization of Membrane Proteins. CRC Press, Boston, MA, 1991.
38. Niedel J, Detergent solubilization of the formyl peptide chemotactic receptor. J Biol Chem 256: 9295-9299, 1981.
39. Norris GE, Baker HM and Baker EN, Preliminary crystallographic studies on human apolactoferrin in its native and glycosylated form. J Mol Biol 209: 329-331, 1989.
40. Prendergast NJ, Delcamp TJ, Smith PL and Freisheim JH, Expression and site-directed mutagenesis of human dihydrofolate reductase. Biochemistry 27: 3664-3671, 1988.
41. 1H NMR spectrum. Biochem Pharmacol 40: 153-160, 1990.
42. 13C resonance assignments of calmodulin in solution by heteronuclear multidimensional NMR spectroscopy. Biochemistry 30: 9216-9228, 1991.